Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Article Type
Date
Availability
1-2 of 2
Keywords: receptor activator of nuclear factor κB ligand (RANKL)
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2007) 112 (11): 567–575.
Published: 01 May 2007
... in cultures to which RANKL was not added ( Figure 2 C). bone resorption C-terminal telopeptide degradation product of type I collagen (CTX-I) cathepsin K metalloproteinase (MMP) osteoclast receptor activator of nuclear factor κB ligand (RANKL) Calcium homoeostasis, skeletal morphogenesis...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2006) 110 (3): 279–291.
Published: 10 February 2006
... apoptosis bone turnover metastatic bone disease osteoprotegerin (OPG) receptor activator of nuclear factor κB ligand (RANKL) tumour cell survival tumour-induced bone disease OPG (osteoprotegerin), a novel secreted member of the TNFR [TNF (tumour necrosis factor) receptor] super-family...
